Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nkarta, Inc. - Common Stock
(NQ:
NKTX
)
2.620
-0.050 (-1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nkarta, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
↗
September 27, 2026
Nkarta (NASDAQ:NKTX) said it expects to present initial clinical data from its autoimmune disease programs at the American College of Rheumatology’s 2026 Convergence meeting in November, including...
Via
MarketBeat
Nkarta to Participate in September Investor Conferences
September 10, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
September 08, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 10, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta (NASDAQ:NKTX) Q1 2026 Narrower Loss Beats Estimates as Autoimmune Trial Advances
↗
May 12, 2026
Via
Chartmill
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
July 23, 2026
From
Cyllene Therapeutics
Via
GlobeNewswire
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 26, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
June 12, 2026
From
Equity Insider
Via
GlobeNewswire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 08, 2026
From
Biotech Insider
Via
GlobeNewswire
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
April 15, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in Needham Virtual Healthcare Conference
April 09, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in March Investor Conferences
February 27, 2026
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in Evercore Healthcare Conference
December 02, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 10, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Participate in November Investor Conferences
October 30, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
October 22, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 28, 2025
Via
Benzinga
Nkarta Posts Narrower Loss in Q2
↗
August 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 12, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
June 06, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space
↗
May 15, 2025
Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.
Via
Benzinga
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
↗
May 15, 2025
Via
Benzinga
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
May 14, 2025
From
Nkarta, Inc.
Via
GlobeNewswire
Top movers in Thursday's session
↗
March 27, 2025
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Top stock movements in today's session.
↗
March 27, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 27, 2025
Via
Benzinga
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
↗
March 27, 2025
Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.
Via
Benzinga
Which stocks are gapping on Thursday?
↗
March 27, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
